JP2025505638A5 - - Google Patents
Info
- Publication number
- JP2025505638A5 JP2025505638A5 JP2024546369A JP2024546369A JP2025505638A5 JP 2025505638 A5 JP2025505638 A5 JP 2025505638A5 JP 2024546369 A JP2024546369 A JP 2024546369A JP 2024546369 A JP2024546369 A JP 2024546369A JP 2025505638 A5 JP2025505638 A5 JP 2025505638A5
- Authority
- JP
- Japan
- Prior art keywords
- peg
- alkyldiyl
- succinimidyl
- alkyl
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263308275P | 2022-02-09 | 2022-02-09 | |
| US63/308,275 | 2022-02-09 | ||
| PCT/US2023/012576 WO2023154307A1 (en) | 2022-02-09 | 2023-02-08 | Antibody-conjugated 8-sulfonyl-benzazepine compounds and their uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505638A JP2025505638A (ja) | 2025-02-28 |
| JP2025505638A5 true JP2025505638A5 (cg-RX-API-DMAC7.html) | 2026-02-12 |
Family
ID=85778754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546369A Pending JP2025505638A (ja) | 2022-02-09 | 2023-02-08 | 抗体コンジュゲート８－スルホニル－ベンザゼピン化合物及びそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250127914A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4475893A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025505638A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240139086A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118843481A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023216956A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL314755A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024009756A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202339806A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023154307A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026050214A1 (en) * | 2024-08-27 | 2026-03-05 | Bolt Biotherapeutics, Inc. | Anti-claudin, tlr agonist immunoconjugates and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6644792B2 (ja) * | 2014-12-18 | 2020-02-12 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ベンザゼピンスルホンアミド化合物 |
| CN108055842B (zh) * | 2015-09-17 | 2021-06-29 | 豪夫迈·罗氏有限公司 | 亚磺酰基苯基或磺亚胺酰基苯基苯并氮杂䓬 |
| CN109311854B (zh) * | 2016-05-23 | 2021-08-10 | 豪夫迈·罗氏有限公司 | 具有仲酰胺官能团的苯并氮杂卓二甲酰胺化合物 |
| AU2019337654A1 (en) * | 2018-09-12 | 2021-04-08 | Silverback Therapeutics, Inc. | Substituted benzazepine compounds, conjugates, and uses thereof |
| US20200390899A1 (en) * | 2019-06-13 | 2020-12-17 | Bolt Biotherapeutics, Inc. | Aminobenzazepine compounds, immunoconjugates, and uses thereof |
| US20220347310A1 (en) * | 2019-09-30 | 2022-11-03 | Bolt Biotherapeutics, Inc. | Amide-linked, aminobenzazepine immunoconjugates, and uses thereof |
| JP7735291B2 (ja) * | 2020-02-21 | 2025-09-08 | エーアールエス ファーマシューティカルズ、インコーポレイテッド | ネクチン－４抗体コンジュゲートおよびその使用 |
| US20230293716A1 (en) * | 2020-05-08 | 2023-09-21 | Bolt Biotherapeutics, Inc. | Elastase-substrate, peptide linker immunoconjugates, and uses thereof |
-
2023
- 2023-02-07 TW TW112104257A patent/TW202339806A/zh unknown
- 2023-02-08 IL IL314755A patent/IL314755A/en unknown
- 2023-02-08 KR KR1020247029749A patent/KR20240139086A/ko active Pending
- 2023-02-08 WO PCT/US2023/012576 patent/WO2023154307A1/en not_active Ceased
- 2023-02-08 EP EP23713985.2A patent/EP4475893A1/en active Pending
- 2023-02-08 CN CN202380026146.0A patent/CN118843481A/zh active Pending
- 2023-02-08 US US18/835,130 patent/US20250127914A1/en active Pending
- 2023-02-08 JP JP2024546369A patent/JP2025505638A/ja active Pending
- 2023-02-08 AU AU2023216956A patent/AU2023216956A1/en active Pending
- 2023-02-08 MX MX2024009756A patent/MX2024009756A/es unknown